Mabwell (Shanghai) Bioscience Co. Ltd. A (688062 SHG) stock market data APIs

¥15.26 -0.73(-4.6%)
as of February 5, 2025

Mabwell (Shanghai) Bioscience Co. Ltd. A Financial Data Overview

Mabwell (Shanghai) Bioscience Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacture, and commercialization of biological products in China and internationally. The company offers its products for oncology, immunology, bone disorders, ophthalmology, hematology and infectious diseases, etc. It offers JUNMAIKANG, an autoimmune Adalimumab injection; MAILISHU for the treatment of postmenopausal women with osteoporosis; JUNMAIKANG, an immunological product; and MAIWEIJIAN for giant cell tumor of bone. The company's oncology products pipeline includes 9MW2821 which is in phase III clinical trial; 6MW3211, which is in phase II of clinical trial; 6MW3211 which is in phase II clinical trial; 9MW2921, 9MW3811, and 7MW3711, which are in phase I clinical trials; and 8MW0511, which has completed phase III clinical trial. It also develops autoimmune products, such as 9MW1911 and 9MW3811, which are in phase 1 clinical trial; hematology product comprising 9MW3011; ophthalmology candidates, including 9MW0813 and 9MW0211 that are in phase III clinical trial; and 9MW1411, an infectious product candidate. The company was founded in 2017 and is headquartered in Shanghai, China.

Prev. Close 15.75
Open 15.26
High 16.82
Low 15.54
52 wk Range 15.36-37
Market Cap 6 390 M
Shares Outstanding 400 M
Revenue 169 M
EPS -0.6034
Beta 1.096

Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Mabwell (Shanghai) Bioscience Co. Ltd. A data using free add-ons & libraries


Get Mabwell (Shanghai) Bioscience Co. Ltd. A Fundamental Data

Mabwell (Shanghai) Bioscience Co. Ltd. A Fundamental data includes:

  • Net Revenue: 169 M
  • EBITDA: -1 017 080 768
  • Earnings Per Share: -2
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Mabwell (Shanghai) Bioscience Co. Ltd. A Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2023-03-31
  • EPS/Forecast: NaN
GET THE PACKAGE

Get Mabwell (Shanghai) Bioscience Co. Ltd. A End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Mabwell (Shanghai) Bioscience Co. Ltd. A News

Get Apple Inc fresh news feed via Financial News API

Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat